1
|
Hofbauer LC, Brueck CC, Singh SK and
Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone
Miner Res. 22:1317–1328. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Janghorbani M, Van Dam RM, Willett WC and
Hu FB: Systematic review of type 1 and type 2 diabetes mellitus and
risk of fracture. Am J Epidemiol. 166:495–505. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Retzepi M and Donos N: The effect of
diabetes mellitus on osseous healing. Clin Oral Implants Res.
21:673–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Yaturu S: Diabetes and skeletal health. J
Diabetes. 1:246–254. 2009. View Article : Google Scholar
|
5
|
Khosla S, Westendorf JJ and Mödder UI:
Concise review: Insights from normal bone remodeling and stem
cell-based therapies for bone repair. Stem Cells. 28:2124–2128.
2010. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Mauney JR, Volloch V and Kaplan DL: Role
of adult mesenchymal stem cells in bone tissue engineering
applications: current status and future prospects. Tissue Eng.
11:787–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Breitbart EA, Meade S, Azad V, et al:
Mesenchymal stem cells accelerate bone allograft incorporation in
the presence of diabetes mellitus. J Orthop Res. 28:942–949.
2010.PubMed/NCBI
|
8
|
Cramer C, Freisinger E, Jones RK, et al:
Persistent high glucose concentrations alter the regenerative
potential of mesenchymal stem cells. Stem Cells Dev. 19:1875–1884.
2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Khan M, Akhtar S, Mohsin S, N Khan S and
Riazuddin S: Growth factor preconditioning increases the function
of diabetes-impaired mesenchymal stem cells. Stem Cells Dev.
20:67–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Jin P, Zhang X, Wu Y, et al:
Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal
cells have impaired abilities in proliferation, paracrine,
antiapotosis, and myogenic differentiation. Transplant Proc.
42:2745–2752. 2010. View Article : Google Scholar
|
11
|
Stolzing A, Sellers D, Llewelyn O and
Scutt A: Diabetes induced changes in rat mesenchymal stem cells.
Cells Tissues Organs. 191:453–465. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Fulzele K and Clemens TL: Novel functions
for insulin in bone. Bone. 50:452–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
AboElAsrar MA, Elbarbary NS, Elshennawy DE
and Omar AM: Iusulin-like growth factor-1 cytokines cross-talk in
type 1 diabetes mellitus: relationship to microvascular
complications and bone mineral density. Cytokine. 59:86–93. 2012.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Gandhi A, Beam HA, O’Connor JP, Parsons JR
and Lin SS: The effects of local insulin delivery on diabetic
fracture healing. Bone. 37:482–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Thaller SR, Lee TJ, Armstrong M, Tesluk H
and Stern JS: Effect of insulin-like growth factor type 1 on
critical-size defects in diabetic rats. J Craniofac Surg.
6:218–223. 1995. View Article : Google Scholar : PubMed/NCBI
|
16
|
Taniguchi CM, Emanuelli B and Kahn CR:
Critical nodes in signaling pathways: insights into insulin action.
Nat Rev Mol Cell Biol. 7:85–96. 2006. View
Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang W, Shen X, Wan C, Zhao Q, Zhang L,
Zhou Q and Deng L: Effects of insulin and insulin-like growth
factor 1 on osteoblast proliferation and differentiation:
differential signalling via Akt and ERK. Cell Biochem Funct.
30:297–302. 2012. View
Article : Google Scholar : PubMed/NCBI
|
18
|
Yang J, Zhang X, Wang W and Liu J: Insulin
stimulates osteoblast proliferation and differentiation through ERK
and PI3K in MG-63 cells: cell biochemistry and function. Cell
Biochem Funct. 28:334–341. 2010. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Fulzele K, Riddle RC, DiGirolamo DJ, et
al: Insulin receptor signaling in osteoblasts regulates postnatal
bone acquisition and body composition. Cell. 142:309–319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang M, Xuan S, Bouxsein ML, et al:
Osteoblast-specific knockout of the insulin-like growth factor
(IGF) receptor gene reveals an essential role of IGF signaling in
bone matrix mineralization. J Biol Chem. 277:44005–44012. 2002.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Xian L, Wu X, Pang L, Lou M, et al: Matrix
IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem
cells. Nat Med. 18:1095–1101. 2012. View
Article : Google Scholar : PubMed/NCBI
|
22
|
Retzepi M, Lewis MP and Donos N: Effect of
diabetes and metabolic control on de novo bone formation following
guided bone regeneration. Clin Oral Implants Res. 21:71–79. 2010.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Jiang X, Zhao J, Wang S, et al: Mandibular
repair in rats with premineralized silk scaffolds and
BMP-2-modified bMSCs. Biomaterials. 30:4522–4532. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zeng D, Xia L, Zhang W, et al: Maxillary
sinus floor elevation using a tissue-engineered bone with
calcium-magnesium phosphate cement and bone marrow stromal cells in
rabbits. Tissue Eng Part A. 18:870–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lü K, Zeng D, Zhang Y, et al: BMP-2 gene
modified canine bMSCs promote ectopic bone formation mediated by a
nonviral PEI derivative. Ann Biomed Eng. 39:1829–1839.
2011.PubMed/NCBI
|
26
|
Wang XJ, Huang H, Yang F, Xia LG, Zhang
WJ, Jiang XQ and Zhang FQ: Ectopic study of tissue-engineered bone
complex with enamel matrix proteins, bone marrow stromal cells in
porous calcium phosphate cement scaffolds, in nude mice. Cell
Prolif. 44:274–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Xia L, Xu Y, Chang Q, et al: Maxillary
sinus floor elevation using BMP-2 and Nell-1 gene-modified bone
marrow stromal cells and TCP in rabbits. Calcif Tissue Int.
89:53–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
McCabe LR: Understanding the pathology and
mechanisms of type 1 diabetic bone loss. J Cell Biochem.
102:1343–1357. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hie M, Iitsuka N, Otsuka T and Tsukamoto
I: Insulin-dependent diabetes mellitus decreases osteoblastogenesis
associated with the inhibition of Wnt signaling through increased
expression of Sost and Dkk1 and inhibition of Akt activation. Int J
Mol Med. 28:455–462. 2011.
|
30
|
Ogata N, Chikazu D, Kubota N, et al:
Insulin receptor substrate-1 in osteoblast is indispensable for
maintaining bone turnover. J Clin Invest. 105:935–943. 2000.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Stokoe D, Macdonald SG, Cadwallader K,
Symons M and Hancock JF: Activation of Raf as a result of
recruitment to the plasma membrane. Science. 264:1463–1467. 1994.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Ge C, Yang Q, Zhao G, Yu H, Kirkwood KL
and Franceschi RT: Interactions between extracellular
signal-regulated kinase 1/2 and p38 MAP kinase pathways in the
control of RUNX2 phosphorylation and transcriptional activity. J
Bone Miner Res. 27:538–551. 2012. View
Article : Google Scholar : PubMed/NCBI
|